A 4-Week Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness
Public ClinicalTrials.gov record NCT03037203. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 4-Week, Double-blind, Placebo-controlled, Randomized, Multicenter, Crossover Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is a 4-week, multicenter, randomized, double-blind, placebo-controlled, ascending dose, 4-period crossover study designed to evaluate the safety, tolerability, efficacy, and PK of JZP-110 (75, 150, and 300 mg) in the treatment of excessive sleepiness in adult subjects with idiopathic PD.
Study identification
- NCT ID
- NCT03037203
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 66 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 35 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2017 (Type not available)
- Primary completion
- Aug 2018 (Actual)
- Completion
- Aug 2018 (Actual)
- Last update posted
- Jan 9, 2020
2017 – 2018
United States locations
- U.S. sites
- 25
- U.S. states
- 14
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Southern California Institute For Respiratory Diseases, Inc. | Los Angeles | California | 90048 | — |
| Pacific Research Network, Inc | San Diego | California | 92103 | — |
| Alpine Clinical Research Center | Boulder | Colorado | 80301 | — |
| Rocky Mountain Movement Disorders Center, PC | Englewood | Colorado | 80113 | — |
| Parkinson's Disease and Movement Disorders Center of Boca Raton | Boca Raton | Florida | 33486 | — |
| PAB Clinical Research | Brandon | Florida | 33511 | — |
| MD Clinical | Hallandale | Florida | 33009 | — |
| QPS MRA (Miami Research Associates) | Miami | Florida | 33143 | — |
| Bioclinica Research | Orlando | Florida | 32806 | — |
| USF Health Byrd Institute | Tampa | Florida | 33613 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| University of Kansas Medical Center Research Institute, Inc. | Kansas City | Kansas | 66160 | — |
| Center for Sleep & Wake Disorders | Chevy Chase | Maryland | 20815 | — |
| QUEST Research Institute | Farmington Hills | Michigan | 48334 | — |
| Clinical Neurophysiology Services, P.C. | Sterling Heights | Michigan | 48314 | — |
| Henry Ford Medical Center - West Bloomfield | West Bloomfield | Michigan | 48322 | — |
| St. Lukes Hospital Medical Center | Chesterfield | Missouri | 63017 | — |
| Strong Sleep Disorders Center | Rochester | New York | 14618 | — |
| Montefiore Sleep-Wake Disorders Center | The Bronx | New York | 10467 | — |
| Lynn Health Science Institute | Oklahoma City | Oklahoma | 73112 | — |
| Parkinson's Disease Research Unit - Thomas Jefferson University | Philadelphia | Pennsylvania | 19107 | — |
| SleepMed of South Carolina | Columbia | South Carolina | 29201 | — |
| Villages at Vanderbilt | Nashville | Tennessee | 37232 | — |
| Evergreen Hospital Medical Center | Kirkland | Washington | 98034 | — |
| Premier Clinical Research - Sherman | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03037203, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 9, 2020 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03037203 live on ClinicalTrials.gov.